Center for Scientific Review; Amended Notice of Meeting, 6674 [2010-2886]

Download as PDF 6674 Federal Register / Vol. 75, No. 27 / Wednesday, February 10, 2010 / Notices discussions of key measure criteria in existence and participants will be asked to identify criteria suitable for the measure development and enhancement work to be supported by the PQMP program. A more specific proposed agenda and instructions for public access to the meeting will be posted before the meeting at https://www.ahrg.gov/chip/ chipraact.htm. The final agenda, including the time for public comment during the meeting, will be available on the AHRQ Web site at https:// www.ahrg.gov/chip/chipraact.htm no later than February 14, 2010. A transcript of the meeting will be available within 21 business days after the meeting. Dated: February 2, 2010. Carolyn M. Clancy, Director. [FR Doc. 2010–2873 Filed 2–9–10; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 25, 2010, 1 p.m. to February 25, 2010, 4 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on February 1, 2010, 75 FR 5092. The meeting will be held February 22, 2010, from 11 a.m. to 2 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: February 2, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–2886 Filed 2–9–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES sroberts on DSKD5P82C1PROD with NOTICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the VerDate Nov<24>2008 16:21 Feb 09, 2010 Jkt 220001 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Auditory, Pain and Chemosensation. Date: March 1–2, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Lynn E. Luethke, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5166, MSC 7844, Bethesda, MD 20892, (301) 806– 3323, luethkel@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Drug Discovery and Development. Date: March 1–2, 2010. Time: 8:30 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Sergei Ruvinov, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892. 301–435– 1180. ruvinser@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Microvascular Interactions. Date: March 3, 2010. Time: 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Manjit Hanspal, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4138, MSC 7804, Bethesda, MD 20892, 301–435– 1195, hanspalm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fellowship: Chemical and Bioanalytical Sciences. Date: March 4, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Denise Beusen, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4142, PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 MSC 7806, Bethesda, MD 20892, (301) 435– 1267, beusend@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Topics in Cancer Research. Date: March 8–9, 2010. Time: 10 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Eun Ah Cho, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD 20892, (301) 451– 4467, choe@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Program Project: National Radiotracer Resource Center. Date: March 14–16, 2010. Time: 6 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: The Parkway Hotel, 4550 Forest Park Avenue, St. Louis, MO 63108. Contact Person: Keith Crutcher, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD 20892, 301–435– 1278, crutcherka@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group, Behavioral and Social Consequences of HIV/ AIDS Study Section. Date: March 15–16, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marina del Rey Marriott, 4100 Admiralty Way, Marina del Rey, CA 90292. Contact Person: Mark P. Rubert, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–806– 6596, rubertm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR Panel: Cancer Health Disparities. Date: March 15–16, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Monaco, 700 F Street, NW., Washington, DC 20001. Contact Person: Nywana Sizemore, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 20892, 301–435– 1718, sizemoren@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: CDIN and CNN Member Applications II. Date: March 15, 2010. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 75, Number 27 (Wednesday, February 10, 2010)]
[Notices]
[Page 6674]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2886]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, February 25, 2010, 1 p.m. to 
February 25, 2010, 4 p.m., National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal 
Register on February 1, 2010, 75 FR 5092.
    The meeting will be held February 22, 2010, from 11 a.m. to 2 p.m. 
The meeting location remains the same.
    The meeting is closed to the public.

    Dated: February 2, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-2886 Filed 2-9-10; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.